Fulcrum Therapeutics FULC 深 滬
已收盤 09-19 16:00:00 美东时间
3.45
+0.010
+0.29%
華盛通- 最 高3.605
- 今 開3.48
- 成交量 109.72万股
- 最 低 3.43
- 昨 收 3.44
- 總市值 2.14亿
- 52周最高 13.70
- 市盈率 靜 --
- 換手率 1.77%
- 52周最低 2.865
- 委 比 -44.02%
- 總股本 6193.52万
- 歷史最高 33.098
- 量 比 0.11
- 振 幅 5.09%
- 歷史最低 2.25
- 每 手 1
- 風險率 2.15%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多FULC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Fulcrum Therapeutics, Inc. and Encourages Investors to Contact the Firm!
NEW YORK-, Sept. 15, 2024 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fulcrum Therapeutics, Inc. ("Fulcrum" or "the Compan...
09-16 04:00
Breaking Down Fulcrum Therapeutics: 7 Analysts Share Their Views
In the preceding three months, 7 analysts have released ratings for Fulcrum The...
09-13 21:00
快讯 | fulcrum therapeutics股票今晨盘前下跌3％，前一个交易日下跌61％
Fulcrum Therapeutics Shares Down 3% Premarket After 61% Drop in Previous Session
09-13 18:21
快讯 | Fulcrum Therapeutics Inc：H.c. Wainwright从买入调降为中立
Fulcrum Therapeutics Inc : H.c. Wainwright Cuts to Neutral From Buy
09-13 18:14
Cantor Fitzgerald Downgrades Fulcrum Therapeutics to Neutral
Cantor Fitzgerald analyst Kristen Kluska downgrades Fulcrum Therapeutics (NASDAQ:FULC) from Overweight to Neutral.
09-12 23:19
Market-Moving News for September 12th
CSBR: 59% | Champions Oncology shares are trading higher after the company reported better-than-expected Q1 financial results. Also, Craig-Hallum upgraded the stock from Hold to Buy and maintained its $6 price
09-12 20:08
Fulcrum crashes as GSK-partnered lead program fails
Fulcrum Therapeutics (NASDAQ:FULC) lost ~70% premarket Thursday after its lead program for protein kinase inhibitor, losmapimod, in-licensed from GSK (NYSE:GSK), failed to reach main goals in patients...
09-12 19:13
新浪财经ESG：FULC 路孚特（Refinitiv）ESG评级调升至C
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
08-28 07:00
纳斯达克生物科技指数收跌0.13%，猴痘疫情概念股普跌
成分股Phathom Pharma收涨12.77%领跑，Verve Therapeutics涨8.02%，Vericel也涨7.25%；Pacific Bio...
08-28 04:54
快讯 | fulcrum therapeutics加强领导团队，任命Isabel Kalofonos为首席商业官和Heather Faulds为首席监管事务和质量保证官。
Fulcrum Therapeutics Strengthens Leadership Team With the Appointments of Isabe...
08-19 19:00
